EX-99.(H)(4) 3 jhct-html1041_ex99h4.htm EXPENSE LIMITATION LETTER AGREEMENT DATED DECEMBER 13, 2018 BETWEEN THE REGISTRANT AND JOHN HANCOCK ADVISERS, LLC

Exhibit (h)(4)

 

John Hancock Advisers, LLC  
601 Congress Street
Boston, MA  02210

 

December 13, 2018

 

To the Trustees of

John Hancock Collateral Trust

601 Congress Street

Boston, MA 02210

Re:      Expense Limitation Letter Agreement

 

With reference to the Advisory Agreement entered into by and between John Hancock Advisers, LLC (the “Adviser”) and John Hancock Collateral Trust (the “Trust”), on behalf of its series John Hancock Collateral Trust (the “Fund”), we hereby notify you as follows:

 

1. The Adviser agrees to contractually waive its advisory fee for the Fund as set forth in the appendix attached hereto.

 

2. We understand and intend that the Trust will rely on this undertaking in accruing the Fund’s expenses for purposes of calculating its net and gross asset value per share, and for other purposes permitted under the Investment Company Act of 1940, as amended, and we expressly permit the Trust so to rely.

 

   

Very truly yours,

 

JOHN HANCOCK ADVISERS, LLC

      By: /s/ Jeffrey H. Long
        Jeffrey H. Long
        Chief Financial Officer

 

Agreed and Accepted

on behalf of John Hancock Collateral Trust

   
By: /s/ Charles A. Rizzo      
  Charles A. Rizzo      
  Chief Financial Officer      
 

 

APPENDIX A

Fund Level Contractual Investment Management Waiver

For purposes of this Appendix:

 

The Adviser contractually agrees to waive its advisory fee by 0.45% of the Fund’s average daily net assets. This fee waiver expires April 30, 2020, unless renewed by mutual agreement of the Fund and the Adviser based upon a determination that this is appropriate under the circumstances at that time.*

 

*At the December 11-13, 2018 meeting of the Board of Trustees of the Trust, the Adviser notified the Board of, and the Board approved, the extension of the expiration date (to April 30, 2020) of the fee waiver arrangement, effective upon the current expiration date of April 30, 2019.

A-1